Aurora Spine (TSXV:ASG) EBIT : C$-0.62 Mil (TTM As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Aurora Spine EBIT?

Aurora Spine's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was C$0.15 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.62 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aurora Spine's annualized ROC % for the quarter that ended in Sep. 2024 was 5.65%. Aurora Spine's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 7.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Aurora Spine's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -1.98%.

Aurora Spine EBIT Historical Data

The historical data trend for Aurora Spine's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Spine EBIT Chart

Aurora Spine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-1.42

-1.49

-2.82

-1.82

-2.01

Aurora Spine Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT	Get a 7-Day Free Trial															-0.27	-0.32	-0.30	-0.15	0.15

Competitive Comparison of Aurora Spine's EBIT

For the Medical Devices subindustry, Aurora Spine's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurora Spine's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aurora Spine's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Aurora Spine EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.62 Mil.

Aurora Spine (TSXV:ASG) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aurora Spine's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	0.616 * ( 1 - 0% )	/	( (11.173	+	10.634)	/ 2 )
=	0.616	/	10.9035
=	5.65 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	16.434	-	4.55	-	( 0.711	-	max(0, 4.963	-	11.659	+	0.711	))
=	11.173

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	16.38	-	4.551	-	( 1.195	-	max(0, 4.947	-	11.87	+	1.195	))
=	10.634

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Aurora Spine's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	0.616	/	( ( (3.064 + max(5.877, 0))	+	(2.782 + max(5.422, 0)) )	/	2 )
=	0.616	/	( ( 8.941	+	8.204 )	/	2 )
=	0.616	/	8.5725
=	7.19 %

where Working Capital is:

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(5.263	+	4.917	+	0.253)	-	(4.55	+	0	+	0.0060000000000002)
=	5.877

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(4.565	+	5.043	+	0.375)	-	(4.551	+	0	+	0.0099999999999998)
=	5.422

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aurora Spine's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	-0.618	/	31.155
	=	-1.98 %

Aurora Spine EBIT Related Terms

Thank you for viewing the detailed overview of Aurora Spine's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurora Spine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aurora Spine Corp (TSXV:ASG) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

ASAPF:USA

Address

20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1

Website

https://www.aurora-spine.com

Aurora Spine Corp is engaged in the business of the development and commercialization of minimally invasive interspinous fusion systems and devices. The product portfolio includes implants, surgical tools, and biologics. It derives revenues primarily from the sale of spinal surgery implants, consumable products used in spinal surgeries, and service revenue for referring products to its customers.

Executives